Soleno Therapeutics SLNO
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2024Q4 | 44.95 | 106.04 | -1.30 | -59,116 | -56 | |
| 2024Q3 | 50.49 | 104.69 | -1.92 | -80,212 | -77 | |
| 2024Q2 | 40.80 | 113.79 | -0.57 | -24,868 | -22 | |
| 2024Q1 | 42.80 | 109.71 | -0.59 | -23,475 | -21 | |
| 2023Q4 | 40.25 | 123.14 | 0.29 | -13,910 | -11 | |
| 2023Q3 | 29.51 | 95.59 | -0.96 | -10,382 | -11 | |
| 2023Q2 | 4.29 | 101.75 | -0.81 | -8,623 | -8 | |
| 2023Q1 | 2.14 | 101.35 | -0.88 | -8,469 | -8 | |
| 2022Q4 | 1.98 | 102.26 | -0.56 | -5,610 | -5 | |
| 2022Q3 | 1.67 | 101.68 | -0.62 | -6,235 | -6 | |
| 2022Q2 | 2.77 | 100.80 | -0.62 | -6,779 | -7 | |
| 2022Q1 | 3.35 | 100.86 | -1.07 | -5,773 | -6 | |
| 2021Q4 | 6.15 | 106.12 | -0.57 | -3,001 | -3 | |
| 2021Q3 | 13.87 | 101.79 | -1.53 | -8,286 | -8 | |
| 2021Q2 | 17.10 | 100.88 | -2.10 | -11,085 | -11 | |
| 2021Q1 | 18.90 | 102.26 | -1.65 | -9,156 | -9 | |
| 2020Q4 | 28.95 | 279.00 | -0.15 | -7,957 | -3 | |
| 2020Q3 | 37.65 | 91.95 | -1.35 | -7,857 | -9 | |
| 2020Q2 | 33.30 | 151.58 | -2.40 | -11,193 | -7 | |
| 2020Q1 | 2.38 | 158.45 | -1.95 | -9,282 | -6 |